Unknown

Dataset Information

0

HCV and HIV co-infection: mechanisms and management.


ABSTRACT: HCV and HIV co-infection is associated with accelerated hepatic fibrosis progression and higher rates of liver decompensation and death compared to HCV monoinfection, and liver disease is a leading cause of non-AIDS-related mortality among HIV-infected patients. New insights have revealed multiple mechanisms by which HCV and HIV lead to accelerated disease progression, specifically that HIV infection increases HCV replication, augments HCV-induced hepatic inflammation, increases hepatocyte apoptosis, increases microbial translocation from the gut and leads to an impairment of HCV-specific immune responses. Treatment of HIV with antiretroviral therapy and treatment of HCV have independently been shown to delay the progression of fibrosis and reduce complications from end-stage liver disease among co-infected patients. However, rates of sustained virologic response with PEG-IFN and ribavirin have been significantly inferior among co-infected patients compared with HCV-monoinfected patients, and treatment uptake has remained low given the limited efficacy and tolerability of current HCV regimens. With multiple direct-acting antiviral agents in development to treat HCV, a unique opportunity exists to redefine the treatment paradigm for co-infected patients, which incorporates data on fibrosis stage as well as potential drug interactions with antiretroviral therapy.

SUBMITTER: Chen JY 

PROVIDER: S-EPMC4330991 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

HCV and HIV co-infection: mechanisms and management.

Chen Jennifer Y JY   Feeney Eoin R ER   Chung Raymond T RT  

Nature reviews. Gastroenterology & hepatology 20140218 6


HCV and HIV co-infection is associated with accelerated hepatic fibrosis progression and higher rates of liver decompensation and death compared to HCV monoinfection, and liver disease is a leading cause of non-AIDS-related mortality among HIV-infected patients. New insights have revealed multiple mechanisms by which HCV and HIV lead to accelerated disease progression, specifically that HIV infection increases HCV replication, augments HCV-induced hepatic inflammation, increases hepatocyte apopt  ...[more]

Similar Datasets

2018-04-09 | PXD009007 | Pride
| S-EPMC5990921 | biostudies-literature
| S-EPMC5381812 | biostudies-literature
| S-EPMC4263235 | biostudies-literature
2011-05-10 | GSE16593 | GEO
2011-05-10 | E-GEOD-16593 | biostudies-arrayexpress
| S-EPMC7539312 | biostudies-literature
| S-EPMC5435870 | biostudies-other
| S-EPMC3602242 | biostudies-literature
| S-EPMC4945024 | biostudies-literature